Download
s00441-020-03240-7.pdf 7,80MB
WeightNameValue
1000 Titel
  • Preservation of optic nerve structure by complement inhibition in experimental glaucoma
1000 Autor/in
  1. Gassel, Caroline J. |
  2. Reinehr, Sabrina |
  3. Gomes, Sara C. |
  4. Dick, H. Burkhard |
  5. Joachim, Stephanie |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-07-17
1000 Erschienen in
1000 Quellenangabe
  • 382(2):293-306
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00441-020-03240-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285355/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Glaucoma is characterized by a progressive damage of the retina and the optic nerve. Despite a huge research interest, the exact pathomechanisms are still unknown. In the experimental autoimmune glaucoma model, rats develop glaucoma-like damage of the retina and the optic nerve after immunization with an optic nerve antigen homogenate (ONA). An early activation of the complement system, even before optic nerve degeneration, was reported in this model. Here, we investigated the effects of a monoclonal antibody against complement factor C5 on optic nerves. Rats were immunized with ONA and compared to controls. In one eye of some ONA animals, the antibody against C5 was intravitreally injected (15 μmol: ONA + C5-I or 25 μmol: ONA + C5-II) before immunization and then every 2 weeks. After 6 weeks, optic nerves were processed for histology (n = 6/group). These analyses demonstrated that the intravitreal therapy reduced the depositions of the membrane attack complex compared to ONA animals (ONA + C5-I: p = 0.005; ONA + C5-II: p = 0.002). Cellular infiltration was significantly reduced in the ONA + C5-I group (p = 0.003), but not in ONA + C5-II tissues (p = 0.41). Furthermore, SMI-32 staining revealed that neurofilament was preserved in both treatment groups compared to ONA optic nerves (both p = 0.002). A decreased amount of microglia was found in treated animals in comparison to the ONA group (ONA + C5-I: p = 0.03; ONA + C5-II: p = 0.009). We observed, for the first time, that a complement system inhibition could prevent optic nerve damage in an autoimmune glaucoma model. Therefore, complement inhibition could serve as a new therapeutic tool for glaucoma.
1000 Sacherschließung
lokal Microglia
lokal Rats [MeSH]
lokal Optic Nerve/physiopathology [MeSH]
lokal Animals [MeSH]
lokal Glaucoma
lokal Complement system
lokal Complement Inactivating Agents/therapeutic use [MeSH]
lokal Male [MeSH]
lokal Rats, Inbred Lew [MeSH]
lokal Glaucoma/physiopathology [MeSH]
lokal Regular Article
lokal Optic nerve
lokal Complement inhibition
lokal Glaucoma/therapy [MeSH]
lokal Disease Models, Animal [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R2Fzc2VsLCBDYXJvbGluZSBKLg==|https://frl.publisso.de/adhoc/uri/UmVpbmVociwgU2FicmluYQ==|https://frl.publisso.de/adhoc/uri/R29tZXMsIFNhcmEgQy4=|https://frl.publisso.de/adhoc/uri/RGljaywgSC4gQnVya2hhcmQ=|https://orcid.org/0000-0001-7056-0829
1000 Hinweis
  • DeepGreen-ID: a95d53f61aa64c7d916e7c1e80ca45b9 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6469452.rdf
1000 Erstellt am 2023-11-17T22:57:10.191+0100
1000 Erstellt von 322
1000 beschreibt frl:6469452
1000 Zuletzt bearbeitet Fri Dec 01 09:51:54 CET 2023
1000 Objekt bearb. Fri Dec 01 09:51:54 CET 2023
1000 Vgl. frl:6469452
1000 Oai Id
  1. oai:frl.publisso.de:frl:6469452 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source